Professor Aebischer is President Emeritus of the Swiss Federal Institute of Technology in Lausanne (EPFL). During his 16-year term as EPFL President, from 2000 to 2016, he transformed the school and established it as a world-calibre university of science and technology. He is also a member of the Brain Mind Institute at EPFL’s School of Life Sciences. Professor Aebischer obtained degrees in medicine (1980) and neuroscience (1983) from the Universities of Geneva and Fribourg. From 1984 to 1992, he was a professor at Brown University’s Department of Neuroscience and Department of Biomaterials, Artificial Organs and Cellular Technology in the US. He returned to Switzerland in autumn 1992 as a full professor at the University of Lausanne and Director of the Division of Surgical Research and the Gene Therapy Centre at the Lausanne University Hospital (CHUV). Prof. Aebischer is a member of the Singapore Health and Biomedical Sciences International Advisory Council (HBMS IAC). He serves on the boards of several not-for-profit organizations including the Swiss Polar Foundation, and the Defitech Foundation. Prof. Aebischer is a member of the Boards of Directors of Nestlé and PolyPeptide, and a former member of the Boards of Directors of Lonza, Logitech and the Novartis Venture Fund (NVF). Prof. Aebischer is a founder of four biotech start-ups.